AGU 100.22 Agrium Inc $AGU Hit a 52 week high of 100.33

New Post Public Reply Private Reply Replies (0) Message Board
DennyT
AGU 100.22 Agrium Inc $AGU Hit a 52 week high of 100.33 Closing the day 09:41 at 100.22 +0.46 +0.46% With a day low of 98.77 and a total volume of 13,919.

AGU Recent Posts: http://investorshangout.com/Agrium-Inc-AGU-50038/

AGU Agrium Inc Recent Headline News

Agrium announces pricing of USD500m debentures offering
M2 - 2 hrs 55 mins ago
Agricultural company Agrium (TSX:AGU.TO) (NYSE:AGU) said on Thursday that it has agreed to issue USD500m aggregate principal amount of 5.25% debentures due 15 January 2045.
AGU: 100.02 (+0.26)

Agrium Prices Offering of $500-Million, 30 Year Debentures
Marketwired - Thu Nov 13, 5:17PM CST
Agrium Inc. (TSX: AGU) (NYSE: AGU) today agreed to issue and sell $500-million aggregate principal amount of 5.25 percent debentures due January 15, 2045. The debentures will be issued at a price of 99.491 percent of the aggregate principal amount. The offering is expected to close on or about November 18, 2014, subject to customary closing conditions. The debentures, registered under the multi-jurisdictional disclosure system in Canada and the United States, will only be offered and sold in the United States.
AGU.TO: 113.56 (+0.14), AGU: 100.02 (+0.26)

Stock Watchout on Chemicals Industry - Mosaic, Agrium, Intrepid Potash, CF Industries Holdings, and Methanex
PR Newswire - Tue Nov 11, 8:00AM CST
Investor-Edge has initiated coverage on the following equities: The Mosaic Company (NYSE: MOS), Agrium Inc. (NYSE: AGU), Intrepid Potash Inc. (NYSE: IPI), CF Industries Holdings Inc. (NYSE: CF), and Methanex Corporation (NASDAQ: MEOH). Free research on these five companies can be accessed at: http://investor-edge.com/register. The US markets on Monday, November 10, 2014, ended on a positive note as the Dow Jones Industrial Average finished at 17,613.74, up 0.23% and the NASDAQ Composite closed at 4,651.62, up 0.41%. The S&P 500 finished the session 0.31% higher at 2,038.26. During the trading session, eight out of ten sectors finished on a higher note. The S&P 500 Materials Sector Index ended the day at 306.58, up 0.26%, with the index advancing 5.11% in the last one month. Register for your complimentary reports on these five stocks at:
CF: 265.72 (-1.40), AGU: 100.02 (+0.26), MOS: 45.24 (-0.16), IPI: 13.69 (-0.16), MEOH: 55.94 (-0.23)

Agrium (AGU) Unit to Acquire Equity Stake in CH Biotech - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Nov 10, 6:05PM CST
Agrium's (AGU) subsidiary Loveland Products has agreed to purchase an equity interest in CH Biotech.
CF: 265.72 (-1.40), AGU: 100.02 (+0.26), MOS: 45.24 (-0.16), POT: 33.50 (+0.04)

10 Stocks Providing Positive Feedback With Increased Dividends
Dividends4Life - at Seeking Alpha - Fri Nov 07, 5:40PM CST

VVC: 44.40 (-0.04), HON: 97.10 (+0.04), AGU: 100.02 (+0.26), AFSI: 51.91 (-0.25), SEP: 56.10 (+0.10), CLNY: 24.79 (+0.12), ATO: 54.39 (-0.12), OZM: 11.46 (-0.12), MCY: 54.76 (-0.13), ROK: 108.95 (+0.79)

CF Industries Misses Earnings and Revenue Estimates in Q3 - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Nov 06, 11:20AM CST
CF Industries (CF) reported a roughly 44% fall in its profit in third-quarter 2014 to $130.9 million or $2.62 per share from $234.1 million or $4.07 per share a year ago, hurt by a double-digit fall in its sales.
CF: 265.72 (-1.40), AGU: 100.02 (+0.26), MOS: 45.24 (-0.16), POT: 33.50 (+0.04)

Agrium agrees for an equity stake in CH Biotech
M2 - Thu Nov 06, 4:49AM CST
Agricultural company Agrium (TSX:AGU.TO) (NYSE:AGU) said on Wednesday that its Loveland Products subsidiary has announced a definitive agreement for an equity stake in CH Biotech, an agricultural technology company.
AGU: 100.02 (+0.26)

A Bigger Payday For Owners Of These 6 Dividend Growers
James Jenckes - at Seeking Alpha - Wed Nov 05, 5:25PM CST

SBUX: 77.98 (+0.09), SE: 38.03 (+0.17), HON: 97.10 (+0.04), AGU: 100.02 (+0.26), EMR: 63.77 (+0.25), EL: 72.15 (-0.40)

Agrium Agrees to Take Equity Stake in CH Biotech R&D
Marketwired - Wed Nov 05, 1:45PM CST
Agrium Inc. (TSX: AGU) (NYSE: AGU), through its subsidiary Loveland Products, Inc., and CH Biotech R&D Co., Ltd. ("CH Biotech" , an agricultural technology company that develops and markets plant health and nutrition technologies, today announced that Loveland Products has signed a definitive agreement to take an equity stake in CH Biotech. Under the terms of the agreement, Agrium will have the right to obtain exclusive, worldwide distribution rights to CH Biotech's existing plant health technologies as well as access to new product and technology opportunities. It will also allow CH Biotech to further collaborate with Agrium to expand their plant health-focused research and development initiatives.
AGU.TO: 113.56 (+0.14), AGU: 100.02 (+0.26)

Agrium's (AGU) CEO Charles Magro on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Tue Nov 04, 2:50PM CST

AGU: 100.02 (+0.26)

Agrium Misses Earnings Estimates in Q3, Hikes Dividend - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 04, 11:30AM CST
Agrium Inc. (AGU) posted profit from continuing operations of $91 million or 63 cents per share in the third quarter of 2014, a rise of around 13.8% from $80 million or 54 cents per share registered a year ago.
CF: 265.72 (-1.40), AGU: 100.02 (+0.26), POT: 33.50 (+0.04)

Agrium (AGU) Q3 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Tue Nov 04, 10:25AM CST

AGU: 100.02 (+0.26)

Update: Agrium - A Call For Patience
Price Point - at Seeking Alpha - Tue Nov 04, 9:23AM CST

AGU: 100.02 (+0.26)

Agrium beats by $0.13, misses on revenue
Seeking Alpha - at Seeking Alpha - Mon Nov 03, 5:34PM CST

AGU: 100.02 (+0.26)

Agrium declares $0.78 dividend
Seeking Alpha - at Seeking Alpha - Mon Nov 03, 5:34PM CST

AGU: 100.02 (+0.26)

Agrium Announces Third Quarter Results and Dividend Increase
Marketwired - Mon Nov 03, 5:33PM CST
ALL AMOUNTS ARE STATED IN U.S.$
AGU.TO: 113.56 (+0.14), AGU: 100.02 (+0.26)

Notable earnings after Monday’s close
Seeking Alpha - at Seeking Alpha - Sun Nov 02, 4:35PM CST

RKT: 55.97 (+0.10), HLF: 37.30 (-0.55), EGAN: 5.32 (-0.06), CUTR: 10.29 (-0.05), DXPE: 66.50 (-0.23), AEIS: 20.24 (-0.29), NOR: 3.91 (-0.05), KBR: 18.85 (+0.12), SGY: 22.38 (+0.52), RTEC: 9.07 (-0.02), PKT: 7.11 (+0.06), OGS: 38.22 (+0.24), BKH: 54.47 (+0.05), KAMN: 41.06 (-0.07), EOX: 2.73 (+0.03), MR: 30.86 (-0.36), RKUS: 12.15 (+0.06), LCI: 48.34 (+0.06), NBIX: 18.98 (-0.16), PQ: 3.96 (+0.01), RBC: 71.36 (+0.21), CHGG: 6.85 (-0.01), AIG: 54.17 (-0.33), MRO: 32.24 (+0.29), GRT: 13.85 (-0.01), EPAM: 48.90 (-0.27), CKP: 12.70 (-0.14), SBRA: 27.59 (-0.06), MDU: 25.22 (+0.22), NTRI: 18.52 (+0.02), ELNK: 4.25 (+0.07), EQC: 25.91 (-0.02), CVD: 100.67 (+0.14), IART: 47.86 (-0.25), FN: 17.41 (-0.09), APL: 32.83 (-0.17), BDE: 8.79 (-0.11), AGU: 100.02 (+0.26), PLOW: 23.02 (+0.06), REG: 61.41 (-0.03), QLYS: 36.14 (+0.47), GALE: 1.88 (unch), ANV: 1.15 (-0.05), ININ: 47.36 (+0.41), FTR: 6.74 (+0.01), GTY: 18.37 (-0.05), MCEP: 16.87 (+0.06), CYH: 46.80 (+0.60), SKH: 7.01 (-0.04), ACXM: 18.48 (-0.05), PL: 69.68 (-0.20), RLD: 11.41 (-0.14), CXW: 36.20 (+0.05), SALE: 14.67 (-0.02), ENH: 57.72 (-0.05), CRK: 11.41 (+0.04), AMTG: 16.29 (+0.08), OTTR: 29.30 (-0.09), NLS: 14.35 (+0.07)

Agrium (AGU) Enters Overbought Territory

Agrium Inc. (AGU) Stock Research Links

AGU Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 15

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 11

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Phase I of 2026 Hong Kong Trade Shows Highlights Innovation

Updated Category News Views 20

Hong Kong Takes Center Stage in Global Commerce Flip through the economic landscape today, and you’ll spot Hong Kong, decked out in its best as a trade linchpin—with over 2,100 suppliers gathered under one roof. AsiaWorld-Expo is buzzing with the commencement of Phase I of the October 2026 Global Sources Hong Kong Shows. The theme's all about 'Connecting Global...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 17

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 22

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 19

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
NARUTO Card Game Set for June 2027 Global Launch

Updated Category News Views 20

Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Southern Company Sparks Swift Power Restoration Post-Isaias

Updated Category News Views 23

Well, when Mother Nature decides to throw a tantrum, it takes seasoned hands and savvy tech to clean up the mess. That's exactly what Southern Company is doing after Hurricane Isaias wreaked havoc on the Southeast. With their electric utilities—Alabama Power, Georgia Power, and Mississippi Power—hitting the ground running, they've already restored power to a whopping...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 18

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading

Top 5 Most Recently Viewed Articles

Insights into Stella-Jones Conference Call for Q3 Results

Updated Category News Views 70

Upcoming Conference Call for Stella-Jones Inc. Stella-Jones Inc. (TSX: SJ), a prominent player in the manufacturing of pressure-treated wood products, is set to hold a significant conference call to discuss its third quarter results. Details of the Conference Call The conference call is open to investors, analysts, and all interested parties. It will take place on...

Continue Reading
Total Voting Rights Announcement for Northern Venture Trust

Updated Category News Views 75

Update on Total Voting Rights Northern Venture Trust PLC has released a key update concerning its total voting rights. In line with the Financial Conduct Authority’s Disclosure Guidance and Transparency Rules, the Company is informing the market about its present capital structure. Overview of Ordinary Shares As per the latest information, Northern Venture Trust PLC's...

Continue Reading
Northrop Grumman Faces Investor Scrutiny Amid Financial Decline

Updated Category News Views 431

Investor Concerns Around Northrop Grumman Investors holding shares in Northrop Grumman Corporation (NYSE: NOC) are facing critical developments as they are encouraged to evaluate their positions in light of recent financial disclosures and ongoing investigations by legal entities. This alert revolves around Northrop Grumman's recent performance and future implications...

Continue Reading
Nature's Sunshine Welcomes Katie May to Board Leadership

Updated Category News Views 420

Nature's Sunshine Embraces New Leadership with Katie A. May Nature's Sunshine Products, Inc. is thrilled to announce that Katie A. May has joined its board of directors, marking a significant step in enhancing leadership and direction within the company. With a rich background in ecommerce and logistics, Katie's new role reflects the company's commitment to further...

Continue Reading
NewAmsterdam Pharma Announces Participation in Key Investor Conferences

Updated Category News Views 79

NewAmsterdam Pharma to Attend Investor Conferences NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS) is a leading biopharmaceutical firm committed to creating innovative oral medications designed to reduce low-density lipoprotein (LDL) cholesterol levels for individuals at risk of cardiovascular disease (CVD). The company is preparing for a series of upcoming investor...

Continue Reading